Science Explorer Interactive view Map
Company · Brisbane · Australia

Leo Pharma (Australia)

In research, Leo Pharma (Australia) stands highest in Medicine (#13,743 of 17,978 worldwide) and Health Sciences (#16,695 of 20,462 worldwide), over all time.

leo-pharma.comROR OpenAlex
World rank, all time
#21,703
of 42,892
Rank in Australia
#406
of 656
Research works
336
▲ 77% vs 2013–17
Citations
7.9k
23.5 per fractional work
Top-10% rate
7.4%
record average 16.5%
Open access
28%
world 28%

What is Leo Pharma (Australia) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #13,743 of 17,978 14.2%123
Health SciencesDomain #16,695 of 20,462 13.5%135

Each strip is that field’s whole ranked pool, with the notch where Leo Pharma (Australia) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.55× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.21× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 7.77× its world share, 3 worksImmunology and Micro…Neuroscience: 0.23× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 13.00× its world share, 2 worksPharmacology, Toxico…Chemistry: 0.76× its world share, 0 worksChemistryComputer Science: 0.32× its world share, 1 worksComputer ScienceEngineering: 0.23× its world share, 1 worksEngineeringEnvironmental Science: 0.17× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.26× its world share, 0 worksMaterials ScienceMathematics: 0.17× its world share, 0 worksMathematicsHealth Professions: 1.84× its world share, 2 worksHealth ProfessionsMedicine: 2.06× its world share, 17 worksMedicineArts and Humanities: 0.59× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.78× its world share, 1 worksBusiness, Management…Decision Sciences: 1.23× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.81× its world share, 1 worksEconomics, Econometr…Psychology: 0.11× its world share, 0 worksPsychologySocial Sciences: 0.51× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.0×. Every wedge is a field page.

Who are the top researchers at Leo Pharma (Australia)?

Ranked on the composite score, Danilo Zardin, Alessandro Rovetta and F. Zanzottera lead among researchers whose main affiliation is Leo Pharma (Australia).

  1. 1 Danilo Zardin Australia · #140,858 worldwide 28 citations · 37 works
  2. 2 Alessandro Rovetta Australia · #308,795 worldwide 3 citations · 53 works
  3. 3 F. Zanzottera Australia · #475,215 worldwide 0 citations · 26 works
  4. 4 Jason M. Foulks Australia · #1,069,868 worldwide 18 citations · 15 works
All ranked researchers at Leo Pharma (Australia)

Which keywords describe research at Leo Pharma (Australia)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immune System, Glycosylation, Immune Dysregulation, Filaggrin, Skin Microbiome, Tumor Microenvironment, Regulatory T Cells and Angiogenesis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology3▲ 1.90×16 topics
  2. Immune System3▲ 26×2 topics
  3. Glycosylation2▲ 54×3 topics
  4. Immune Dysregulation2▲ 74×2 topics
  5. Filaggrin2▲ 113×1 topic
  6. Quality of Life2▲ 3.8×10 topics
  7. Skin Microbiome2▲ 113×1 topic
  8. Cancer2▲ 3.8×9 topics
  9. Tumor Microenvironment2▲ 11×6 topics
  10. Chemotherapy2▲ 6.5×9 topics
  11. Regulatory T Cells2▲ 40×2 topics
  12. Angiogenesis2▲ 13×4 topics
  13. Immune Response2▲ 7.4×5 topics
  14. Metastasis2▲ 12×5 topics
  15. TGF-ß2▲ 28×2 topics
  16. Cell Differentiation2▲ 43×2 topics
  17. IL-172▲ 124×1 topic
  18. TH17 Cells2▲ 124×1 topic
  19. Cancer Progression2▲ 20×3 topics
  20. Diagnosis2▲ 3.9×7 topics
  21. Monoclonal Antibodies2▲ 41×2 topics
  22. Therapeutic Antibodies2▲ 53×2 topics
  23. Antibody Engineering1▲ 60×1 topic
  24. Fc Receptors1▲ 60×1 topic
  25. Management1▲ 4.1×6 topics
  26. HIF-11▲ 51×1 topic
  27. Monoclonal Antibody1▲ 61×2 topics
  28. Smad-dependent pathways1▲ 431×1 topic
  29. Tumor Suppression1▲ 44×1 topic
  30. Warburg Effect1▲ 51×1 topic
  31. Adverse Drug Reactions1▲ 54×3 topics
  32. Metastatic1▲ 45×2 topics
  33. Breast Cancer1▲ 11×2 topics
  34. Cancer Immunotherapy1▲ 17×3 topics
  35. EGFR1▲ 84×1 topic
  36. HER21▲ 84×1 topic
  37. Healthcare Policy1▲ 25×1 topic
  38. Inequalities1▲ 68×1 topic
  39. Open Innovation1▲ 38×1 topic
  40. Trastuzumab1▲ 53×2 topics

Which research topics does Leo Pharma (Australia) publish most on?

By volume in 2022–2025: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Monoclonal and Polyclonal Antibodies Research and TGF-β signaling in diseases.

Dermatology and Skin Diseases: 2 fractional worksPsoriasis: Treatment and Pathogenesis: 2 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksTGF-β signaling in disea…1TGF-β signaling in diseases: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksInnovative Approaches in Technology and Social Development: 1 fractional worksHealthcare Systems and P…1Healthcare Systems and Practices: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksLinguistic, Cultural, and Literary Studies: 1 fractional works
DermatologyImmunologyRadiology, Nuclear Medicine and ImagingMolecular Biology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 2 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 TGF-β signaling in diseases Molecular Biology 1 works
  5. 5 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  6. 6 Innovative Approaches in Technology and Social Development Management of Technology and Innovation 1 works
  7. 7 Healthcare Systems and Practices General Health Professions 1 works
  8. 8 HER2/EGFR in Cancer Research Oncology 1 works
  9. 9 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  10. 10 Linguistic, Cultural, and Literary Studies Sociology and Political Science 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.1%not open71.9%

World: 28% of research is openly available.

with international co-authors50.9%domestic only49.1%

World: 19% is written across borders.

How has Leo Pharma (Australia)'s research output changed?

Output in 2018–2022 was 77% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Brisbane

All research institutions in Brisbane

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.